Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder, characterized by a low platelet count (<100 × 10(9)/L) in the absence of other causes associated with thrombocytopenia. In most patients, IgG autoantibodies directed against platelet receptors can be detected. They...

Descripción completa

Detalles Bibliográficos
Autores principales: Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., de Haard, Hans, Leupin, Nicolas, Kuter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004056/
https://www.ncbi.nlm.nih.gov/pubmed/31821591
http://dx.doi.org/10.1002/ajh.25680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004056/
https://www.ncbi.nlm.nih.gov/pubmed/31821591
http://dx.doi.org/10.1002/ajh.25680

Ejemplares similares